Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 10 studies | 27% ± 8% |
Insufficient scRNA-seq data for expression of IL5RA at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 93% | 126.30 | 227 / 245 | 48% | 4.83 | 243 / 502 |
lung | 99% | 242.03 | 570 / 578 | 18% | 0.52 | 204 / 1155 |
spleen | 100% | 146.61 | 241 / 241 | 0% | 0 | 0 / 0 |
stomach | 73% | 22.51 | 263 / 359 | 1% | 0.02 | 3 / 286 |
bladder | 71% | 26.48 | 15 / 21 | 2% | 0.04 | 9 / 504 |
intestine | 71% | 36.44 | 682 / 966 | 1% | 0.01 | 4 / 527 |
peripheral blood | 70% | 77.36 | 648 / 929 | 0% | 0 | 0 / 0 |
esophagus | 64% | 23.86 | 923 / 1445 | 1% | 0.01 | 1 / 183 |
adipose | 61% | 17.11 | 731 / 1204 | 0% | 0 | 0 / 0 |
uterus | 55% | 51.30 | 93 / 170 | 4% | 0.15 | 18 / 459 |
heart | 51% | 51.88 | 439 / 861 | 0% | 0 | 0 / 0 |
breast | 45% | 11.32 | 205 / 459 | 3% | 0.07 | 33 / 1118 |
kidney | 46% | 19.47 | 41 / 89 | 1% | 0.02 | 10 / 901 |
skin | 39% | 10.11 | 705 / 1809 | 2% | 0.04 | 9 / 472 |
thymus | 39% | 13.35 | 254 / 653 | 1% | 0.01 | 5 / 605 |
ovary | 16% | 5.18 | 29 / 180 | 18% | 0.66 | 76 / 430 |
brain | 29% | 60.14 | 767 / 2642 | 2% | 0.21 | 15 / 705 |
blood vessel | 21% | 5.47 | 282 / 1335 | 0% | 0 | 0 / 0 |
liver | 16% | 2.62 | 36 / 226 | 0% | 0 | 0 / 406 |
pancreas | 13% | 2.17 | 43 / 328 | 2% | 0.04 | 3 / 178 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.60 | 4 / 29 |
adrenal gland | 7% | 1.10 | 17 / 258 | 3% | 0.08 | 6 / 230 |
muscle | 2% | 0.30 | 15 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0002437 | Biological process | inflammatory response to antigenic stimulus |
GO_0032674 | Biological process | regulation of interleukin-5 production |
GO_0038043 | Biological process | interleukin-5-mediated signaling pathway |
GO_0070665 | Biological process | positive regulation of leukocyte proliferation |
GO_0005615 | Cellular component | extracellular space |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0004914 | Molecular function | interleukin-5 receptor activity |
GO_0019955 | Molecular function | cytokine binding |
GO_0005515 | Molecular function | protein binding |
GO_0004896 | Molecular function | cytokine receptor activity |
Gene name | IL5RA |
Protein name | Interleukin 5 receptor alpha transcript variant 7 Interleukin 5 receptor subunit alpha Interleukin-5 receptor subunit alpha (IL-5 receptor subunit alpha) (IL-5R subunit alpha) (IL-5R-alpha) (IL-5RA) (CDw125) (CD antigen CD125) Interleukin 5 receptor, alpha |
Synonyms | IL5R |
Description | FUNCTION: Cell surface receptor that plays an important role in the survival, differentiation, and chemotaxis of eosinophils . Acts by forming an heterodimeric receptor with CSF2RB subunit and subsequently binding to interleukin-5 . In unstimulated conditions, interacts constitutively with JAK2. Heterodimeric receptor activation leads to JAK2 stimulation and subsequent activation of the JAK-STAT pathway . . |
Accessions | C9J6C4 ENST00000383846.5 [Q01344-2] ENST00000446632.7 [Q01344-1] Q01344 ENST00000438560.5 [Q01344-4] ENST00000430514.6 [Q01344-3] ENST00000456302.5 [Q01344-3] ENST00000311981.12 [Q01344-2] ENST00000256452.7 [Q01344-1] ENST00000418488.6 B3IU76 ENST00000445701.5 ENST00000427088.1 C9J3K8 Q8NHV7 E7ERY4 |